IVTech
IVTech srl, founded 2014 as a University of Pisa spin-off, designs and sells a modular fluidic platform — transparent bioreactor chambers, peristaltic pumps, and environmental controls — that enables 5D in-vitro models for pharmaceutical, cosmetics, and academic research customers seeking alternatives to animal testing.
- Company typePrivate
- Founded2014
- HeadquartersMassarosa, Italy
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What IVTech does
IVTech srl is an Italian life-science instrumentation company founded in 2014 as a spin-off of the University of Pisa. The company designs, manufactures, and commercializes a modular fluidic platform for building 5D (five-dimensional) in-vitro models as alternatives to standard 2D cell culture and animal testing. The core product line consists of transparent bioreactor chambers (LiveBox1, LiveBox2), a semi-disposable multi-chamber rack (MultiDyn, launched early 2024), incubator-compatible peristaltic pumps (ONE, LiveFlow), and add-on analytical modules including a hydrodynamic pressure controller (LivePa) and a real-time TEER reader (LiveT, launched May 2025). The platform is engineered to maintain compatibility with standard multiwell plates, transwells, and standard microscopy workflows, lowering adoption friction for research laboratories.
The company serves pharmaceutical and biotechnology companies (drug discovery and toxicology), cosmetics companies (regulatory-driven alternatives to animal testing), academic and research institutions (tissue engineering, organoids, disease modeling), and medical research institutions and hospitals. The business model combines recurring hardware unit sales of chambers, pumps, and control units with engineering services (fluid dynamic characterization), customization work, and collaborative biological model development. IVTech distributes directly through quote-request-driven website sales and through a regional distributor network spanning Italy, Slovenia, Czech Republic, Spain, Portugal, South Korea, Australia, the United States, and Israel, with two new distributor agreements (Amerigo Scientific in the USA, Paralab in Spain and Portugal) added in 2024.
Operating from Ospedaletto (Pisa) with a team in the 1-10 range, IVTech has been funded primarily through Italian regional and national R&D grants — including SOFIA (Regione Toscana, 2021-2022), LiveSens and Lassie (Artes 4.0, 2021), and the EMILE project (coordinated by IVTech, Regione Toscana, November 2024 to March 2026) — alongside a single small 2015 equity infusion from EISMEA. The company is privately held, has no parent organization, and discloses no revenue figures.
IVTech firmographics
Firmographics- Name
- IVTech
- Legal name
- IVTech srl
- Website
- https://ivtech.it
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- IVTech srl, founded 2014 as a University of Pisa spin-off, designs and sells a modular fluidic platform — transparent bioreactor chambers, peristaltic pumps, and environmental controls — that enables 5D in-vitro models for pharmaceutical, cosmetics, and academic research customers seeking alternatives to animal testing.
- Ownership category
- akta.pro rank
IVTech industry classification
Industry- Product category
- In-vitro bioreactor systems
- NAICS
- Measuring, Dispensing, and Other Pumping Equipment Manufacturing (333914), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Laboratory Apparatus & Furniture (3821), Pumps & Pumping Equipment (3561)
- akta.pro primary industry
- Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG)
- akta.pro secondary industry
- In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems) (HLAAAIAJ)
Keywords
Where IVTech is headquartered
LocationHeadquarters
- HQ city
- Massarosa
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
IVTech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Bioreactors and fluidic platform products: Sale of hardware products including LiveBox1, LiveBox2, and MultiDyn chambers for dynamic in-vitro cell culture. One-time product sales with reusable components.
- Peristaltic pumps: Sale of pumping equipment (ONE and LiveFlow) that provide fluid flow for dynamic models. Hardware product sales.
- Environmental control units: Sale of LivePa pressure modulation equipment for simulating physiological and pathological environmental conditions.
- Engineering services: Fluid dynamic studies and scale laws to characterize models a priori, providing technical support for model development.
- Customization services: Development of ad-hoc technologies tailored to specific customer requirements.
- Biological models development: Development of biological models in collaboration with partners, supporting customers in developing predictive in-vitro models.
Go-to-market motion3 records
Distribution channels8 records
Marketing channels6 records
IVTech product offering
Product offeringCore offering
IVTech designs, manufactures, and sells a modular fluidic platform of transparent bioreactor chambers (LiveBox1, LiveBox2, MultiDyn), peristaltic pumps (ONE, LiveFlow), and environmental control units (LivePa, LiveT) used by researchers to build 5D dynamic in-vitro cell-culture models that serve as alternatives to animal testing. The company also provides engineering studies, customization, and biological-model-development services to support customers adapting the platform to specific tissues and disease models.
Product overview
IVTech offers a modular fluidic platform for developing 5D (five-dimensional) in-vitro models. The core product line consists of transparent bioreactor chambers (LiveBox1, LiveBox2), a multi-chamber rack system (MultiDyn), peristaltic pumps (ONE, LiveFlow), and environmental control units (LivePa, LiveT). LiveBox1 and LiveBox2 are the primary cell culture chambers, with LiveBox1 designed for attached cell culture and LiveBox2 for barrier mimicry in ALI/LLI conditions. MultiDyn extends these with parallel experimentation capability. The ONE and LiveFlow peristaltic pumps serve as the fluidic drive system, while LivePa adds pressure modulation and LiveT provides real-time TEER monitoring. The platform is designed to maintain standard cell culture protocols while adding dynamicity to static models. IVTech also provides engineering, customization, and biological model development services.
Differentiator
Problem solved
Functional benefit
Products and services
- LiveBox1 (LB1) Transparent bioreactor chamber for developing dynamic in-vitro models in attached cell culture conditions, maintaining compatibility with standard cell culture and monitoring protocols, including multiwell plates (6, 12, 24) and standard microscopes.
- LiveBox2 (LB2) Transparent bioreactor designed to mimic patho-physiological barriers under dynamic conditions in both air-liquid interface (ALI) and liquid-liquid interface (LLI) configurations, equipped with a porous and removable membrane compatible with standard transwell inserts.
- MultiDyn (MD) Compact semi-disposable multi-dynamic-chambers rack based on 24-well plate dimensions, equipped with 4 wells that can be autonomously perfused for parallel dynamic in-vitro models. Modular design allows joining multiple MD units for customized fluidic platforms.
- ONE (Our New Environment) Low-weight, compact peristaltic pump compatible with incubator environments, available in 4- and 8-fluidic-circuit versions with independent motors supporting same or different flow rates. Features removable plates for sterile transfer and Android-app remote control.
- LiveFlow (LF) Compact, low-weight peristaltic pump compatible with incubator environments, equipped with 2 independent motors enabling up to 2 different flows simultaneously in constant or programmable modalities. Removable, autoclavable heads carry 2 tubes each, supporting reproduction of interstitial flow in real tissue.
- LivePa Environmental control unit that increases hydrodynamic pressure in dynamic in-vitro models to simulate disease scenarios (such as hypertension and glaucoma) or physiological evolutions (such as pressure changes during food ingestion). Compatible with LB1, LB2 (ALI), and LB2 (LLI) chambers and acts as an external device that maintains sterility.
- LiveT Real-time TEER (Trans-Epithelial Electrical Resistance) reader for monitoring tissue barrier integrity in real time during dynamic in-vitro experiments.
- Engineering services Fluid dynamic studies and scale-law analyses to characterize in-vitro models a priori, providing technical support for customers developing predictive in-vitro models on the IVTech platform.
- Customization services Development of ad-hoc technologies tailored to specific customer requirements for advanced in-vitro models, extending the IVTech fluidic platform into customer-defined applications.
- Biological model development services Development of biological models in collaboration with partners, supporting customers in building predictive in-vitro models across multiple tissue and disease areas.
Companies that use IVTech
Customer profileSegments4 records
Ideal customer profiles4 records
IVTech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
IVTech partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- NAMina BioSciencecoreNew collaboration to build a Translational Architecture combining organoids, fluidic platforms, 3D bioprinting, and AI analytics into coherent, human-relevant experimental workflows. Focus on physiologically relevant modeling, cross-platform interoperability, and context-specific validation aligned with regulatory expectations.
- Istituto di Fisiologia Clinica CNR-PisacoreCollaboration partner in EMILE project (advanced atherosclerotic vascular model) and SOFIA project (vascular calcification model). Provides scientific expertise for advanced in-vitro model development.
- Giotto Biotech SrlminorProject partner in EMILE project for advanced atherosclerotic vascular model development.
- BeeApp SrlminorProject partner in EMILE project for advanced atherosclerotic vascular model development.
- Laboratori Aliveda srlminorPartner in SOFIA project (vaScular mOdel For In-vitro cAlcification) focused on nutraceutical development and in-vitro testing platform.
- Faserem srlminorPartner in SOFIA project for vascular calcification model development and new platform development.
- Adatec Sensing & Automation srlminorPartner in Lassie project (pLAtform for advanced teSt of viruS and tissuE) applying IoT concept to fluidic technology for studying diseases including COVID-19.
Scale indicators4 records
Recent moves7 records
Expansion highlights5 records
IVTech competitors and assessment
Company assessmentDirect peers
- Emulate: US-based organ-on-chip company whose EmuChip and Liver-Chip platforms compete head-on with IVTech's LiveBox/MultiDyn dynamic in-vitro chambers for pharma drug-discovery and toxicity-testing workflows.
- TissUse: German multi-organ-chip company whose HUMIMIC platforms couple multiple organoid models via microfluidic flow, the same fundamental concept IVTech uses in MultiDyn multi-chamber perfusion.
- Mimetas: Dutch company marketing the OrganoPlate, a microfluidic 3D cell-culture plate targeting the same organoid/perfusion application niches (kidney, gut, vasculature) as IVTech's fluidic platform.
- Kirkstall: UK company marketing the Quasi-Vivo system of interconnected perfused chambers, an early and direct technical analog of IVTech's peristaltic-pump-driven LiveBox/ONE setups.
- SynVivo: US-based microfluidic organ-on-chip vendor whose chips recapitulate in vivo fluid shear and barrier transport conditions overlapping with IVTech's ALI/LLI LiveBox2 applications.
- CN Bio: UK-headquartered organ-on-chip vendor (PhysioMimix, Liver-Chip) selling microphysiological systems to pharma that directly overlap with IVTech's barrier and liver-model LiveBox2 use cases.
- InSphero: Swiss 3D-microtissue and organoid screening vendor whose Akura flow plate overlaps with IVTech's spheroid/organoid perfusion application areas in drug-discovery and toxicology.
- MatTek Life Sciences: US producer of 3D in-vitro tissue models (EpiDerm, EpiOcular) for cosmetics and chemical safety testing, addressing the same animal-test-replacement end-customer that IVTech targets with its LiveBox-based barrier models.
Emerging players
- CelVivo: Danish company offering clinostat-based 3D cell-culture (spheroid/organoid) systems that compete with IVTech's live-cell perfusion approaches for academic and pharma in-vitro modelling.
- ibidi: German supplier of cell-culture and microfluidic chips (ibiTreat, µ-Slide) whose products, especially perfusion channels, are partially substitutable with IVTech's flow-based bioreactors for academic microscopy workflows.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
IVTech social profiles
Digital presenceIVTech financial estimates
Financial estimateRevenue estimate
Valuation estimate
IVTech leadership team
Management profileNumber of profiles
Profiles8 records
IVTech funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IVTech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IVTech
What does IVTech do?
IVTech designs, manufactures, and sells a modular fluidic platform of transparent bioreactor chambers (LiveBox1, LiveBox2, MultiDyn), peristaltic pumps (ONE, LiveFlow), and environmental control units (LivePa, LiveT) used by researchers to build 5D dynamic in-vitro cell-culture models that serve as alternatives to animal testing. The company also provides engineering studies, customization, and biological-model-development services to support customers adapting the platform to specific tissues and disease models.
Is IVTech a public or private company?
IVTech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was IVTech founded?
IVTech was founded in 2014. It employs 1 to 10 people.
Where is IVTech based?
IVTech is headquartered in Massarosa, Italy, in the Europe region.
How does IVTech make money?
Six revenue lines are on record. Bioreactors and fluidic platform products are the primary driver. The others are peristaltic pumps, environmental control units, engineering services, customization services and biological models development.
Who are IVTech's main competitors?
Direct peers on record are Emulate, TissUse, Mimetas, Kirkstall, SynVivo, CN Bio, InSphero and MatTek Life Sciences. Emerging players are CelVivo and ibidi.
Does IVTech have an API?
No public API is recorded for IVTech.
What industry is IVTech in?
IVTech's product category is In-vitro bioreactor systems. Its primary akta.pro industry code is HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers), with a secondary code of HLAAAIAJ, In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems). Its NAICS code is 333914 and its SIC code is 3821.